Finished Drug for HIV Treatment Lamivudinum 3tc&Viramune&Stavudinum Tablet

Model NO.: DAWA972


Usage Mode: For oral administration


Shape: Tablet


Pharmaceutical Technology: Chemical Synthesis


Specifications: 150mg+200mg+30mg


OEM: Acceptable


Trademark: GUYENNE


Origin: France




Application: Internal Medicine


State: Solid


Type: Biological Products


Product Name: Lamivudinum 3tc&Viramune&Stavudinum Tablet


Packing: 30tabs/Bottle


Caution: Consulting The Doctor


Specification: GMP/WHO GMP/EURO GMP


HS Code: 2923900090


Product Description

Anti-HIV Lamivudinum 3TC &Viramune&Stavudinum tablet

Each tablet contains:

Lamivudinum	Viramune	Stavudinum
150mg	200mg	30mg

Pharmacodynamics:

1.Lamivudinum is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV). Lamivudinum is phosphorylated to active metabolites that compete for incorporation into viral DNA. They inhibit the HIV reverse transcriptase enzyme competitively and act as a chain terminator of DNA synthesis. The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.

2.Viramune is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by Viramune.Viramune is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to Viramune if the drug is taken alone, although even if used properly, Viramune is effective for only a limited time.

3Stavudinum is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Stavudinum is phosphorylated to active metabolites that compete for incorporation into viral DNA. They inhibit the HIV reverse transcriptase enzyme competitively and act as a chain terminator of DNA synthesis. The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.

Attention: Keep out of reach of children.

Store below 25°c.

Protect from light.

For full information,pls consult enclosed leaflet.

Contact us if you need more details on Lamivudinum 3tc&Viramune&Stavudinum Tablet. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Anti-HIV、Lamivudinum 3tc. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Anti-Hiv Drug